Stay updated on Pembrolizumab in Poor-Prognosis CUP Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Poor-Prognosis CUP Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Poor-Prognosis CUP Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    Revision updated from v3.3.1 to v3.3.2 on the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-28T02:15:48.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    Revision v3.3.1 was added and Revision v3.2.0 was removed from the page.
    Difference
    0.1%
    Check dated 2025-11-20T22:05:23.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    The government funding status notice banner was removed from the page. The study details and page structure remain unchanged.
    Difference
    0.4%
    Check dated 2025-11-13T15:33:04.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    Enrollment has been updated to 26 participants and the last update date is 2025-04-25. There are also minor textual revisions to sections such as eligibility criteria.
    Difference
    0.4%
    Check dated 2025-10-30T11:11:55.000Z thumbnail image
  7. Check
    76 days ago
    Change Detected
    Summary
    Updated the revision label from v3.0.2 to v3.2.0, indicating a newer version has been released. No other content changes observed.
    Difference
    0.1%
    Check dated 2025-10-01T02:49:47.000Z thumbnail image
  8. Check
    77 days ago
    Change Detected
    Summary
    Version bumped from v3.0.2 to v3.1.0; no other content changes were provided.
    Difference
    0.1%
    Check dated 2025-09-30T02:51:37.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Poor-Prognosis CUP Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Poor-Prognosis CUP Clinical Trial page.